Todd Nelson
SGI-DNA has appointed Todd Nelson as CEO to lead its spin out from Synthetic Genomics. Nelson has led several life sciences companies through phases of financial and commercial growth, including eBioscience (which was acquired by Affymetrix), MP Biomedicals (which was acquired by Valeant Fine Chemicals), and DiscoverX Corporation (now Eurofins), SGI-DNA said. He is also the founder of Tonbo Biosciences and TCRx Corporation.
Armin Winands and Jan Hellemans
Belgian genomics service provider Biogazelle has appointed Armin Winands as its new CEO. Winands most recently served as director of business development at ArcherDX. Over the past 23 years, he has also held senior sales positions at NuGEN Technologies, Ingenuity Systems, Ion Torrent Systems, Illumina, Affymetrix, and Molecular Dynamics. Winands replaces Jan Hellemans, who served as CEO of Biogazelle for the past 10 years and will now take on the role of chief technology officer.
Paul Kinnon
Paul Kinnon has been appointed CEO of PredictImmune in Cambridge, UK. He previously held leadership positions at Transgenomic, ZyGem, Life Technologies, Guava Technologies, and Cellomics. Kinnon started his career as an analytical chemist at Smithkline French & Beckman Research, a predecessor of GlaxoSmithKline.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.